Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Safety of hepatic resection for colorectal metastases in the era of neo-adjuvant chemotherapy.

Cucchetti A, Ercolani G, Cescon M, Di Gioia P, Peri E, Brandi G, Pellegrini S, Pinna AD.

Langenbecks Arch Surg. 2012 Mar;397(3):397-405. doi: 10.1007/s00423-011-0894-4. Epub 2011 Dec 24.

PMID:
22198370
2.

Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases.

Ercolani G, Cucchetti A, Cescon M, Peri E, Brandi G, Del Gaudio M, Ravaioli M, Zanello M, Pinna AD.

Eur J Cancer. 2011 Oct;47(15):2291-8. doi: 10.1016/j.ejca.2011.05.014. Epub 2011 Jun 7. Review.

PMID:
21652204
3.

Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter?

Pinto Marques H, Barroso E, de Jong MC, Choti MA, Ribeiro V, Nobre AM, Carvalho C, Pawlik TM.

J Surg Oncol. 2012 May;105(6):511-9. doi: 10.1002/jso.22133. Epub 2011 Nov 7.

PMID:
22065486
4.

Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes.

Sahajpal A, Vollmer CM Jr, Dixon E, Chan EK, Wei A, Cattral MS, Taylor BR, Grant DR, Greig PD, Gallinger S.

J Surg Oncol. 2007 Jan 1;95(1):22-7.

PMID:
17066435
5.

Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.

Knowles B, Welsh FK, Chandrakumaran K, John TG, Rees M.

HPB (Oxford). 2012 May;14(5):298-309. doi: 10.1111/j.1477-2574.2012.00447.x. Epub 2012 Feb 28.

6.

The use of neo-adjuvant chemotherapy in patients with resectable colorectal liver metastases: Clinical risk score as possible discriminator.

Ayez N, van der Stok EP, Grünhagen DJ, Rothbarth J, van Meerten E, Eggermont AM, Verhoef C.

Eur J Surg Oncol. 2015 Jul;41(7):859-67. doi: 10.1016/j.ejso.2015.04.012. Epub 2015 May 2.

PMID:
25979624
7.

Neoadjuvant chemotherapy for resectable colorectal liver metastases: what is the evidence? Results of a systematic review of comparative studies.

Nigri G, Petrucciani N, Ferla F, La Torre M, Aurello P, Ramacciato G.

Surgeon. 2015 Apr;13(2):83-90. doi: 10.1016/j.surge.2014.07.005. Epub 2014 Sep 23. Review.

PMID:
25257725
8.

Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi-center data analysis using LiverMetSurvey.

Bonney GK, Coldham C, Adam R, Kaiser G, Barroso E, Capussotti L, Laurent C, Verhoef C, Nuzzo G, Elias D, Lapointe R, Hubert C, Lopez-Ben S, Krawczyk M, Mirza DF; LiverMetSurvey International Registry Working Group.

J Surg Oncol. 2015 May;111(6):716-24. doi: 10.1002/jso.23899. Epub 2015 Apr 9.

PMID:
25864987
9.

Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases: a ten year study.

Karanjia ND, Lordan JT, Fawcett WJ, Quiney N, Worthington TR.

Eur J Surg Oncol. 2009 Aug;35(8):838-43. doi: 10.1016/j.ejso.2008.09.017. Epub 2008 Nov 17.

PMID:
19010633
10.

Hepatectomy after hepatic arterial therapy with either yttrium-90 or drug-eluting bead chemotherapy: is it safe?

Brown RE, Bower MR, Metzger TL, Scoggins CR, McMasters KM, Hahl MJ, Tatum C, Martin RC.

HPB (Oxford). 2011 Feb;13(2):91-5. doi: 10.1111/j.1477-2574.2010.00246.x. Epub 2010 Dec 22.

11.

Hepatic Resection After Prehepatectomy Chemotherapy for Metastatic Colorectal Cancer: A Propensity-Matched Analysis.

Kawaguchi D, Hiroshima Y, Matsuo K, Endo I, Koda K, Tanaka K.

Anticancer Res. 2016 Sep;36(9):4725-30.

PMID:
27630319
12.

Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.

Brandi G, Derenzini E, Falcone A, Masi G, Loupakis F, Pietrabissa A, Pinna AD, Ercolani G, Pantaleo MA, Di Girolamo S, Grazi GL, de Rosa F, Biasco G.

Clin Colorectal Cancer. 2013 Sep;12(3):188-94. doi: 10.1016/j.clcc.2013.04.002. Epub 2013 Jun 14.

PMID:
23773458
13.

Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?

Reddy SK, Tsung A, Marsh JW, Geller DA.

J Surg Oncol. 2012 Jan;105(1):55-9. doi: 10.1002/jso.22044. Epub 2011 Aug 12.

PMID:
21842519
14.

Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases.

Andreou A, Kopetz S, Maru DM, Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, Aloia TA, Vauthey JN.

Ann Surg. 2012 Oct;256(4):642-50. doi: 10.1097/SLA.0b013e31826b4dcc.

15.

Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis.

Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero D, Abdalla EK, Choti MA, Kemp C, Vauthey JN, Morse MA, White RR, Clary BM.

Ann Surg Oncol. 2009 Jul;16(7):1809-19. doi: 10.1245/s10434-008-0181-y. Epub 2008 Nov 1.

PMID:
18979139
16.

Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.

Morris-Stiff G, White AD, Gomez D, Cameron IC, Farid S, Toogood GJ, Lodge JP, Prasad KR.

Eur J Surg Oncol. 2014 Aug;40(8):1016-20. doi: 10.1016/j.ejso.2013.09.015. Epub 2013 Nov 1.

PMID:
24370284
17.

Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial.

Ayez N, van der Stok EP, de Wilt H, Radema SA, van Hillegersberg R, Roumen RM, Vreugdenhil G, Tanis PJ, Punt CJ, Dejong CH, Jansen RL, Verheul HM, de Jong KP, Hospers GA, Klaase JM, Legdeur MC, van Meerten E, Eskens FA, van der Meer N, van der Holt B, Verhoef C, Grünhagen DJ.

BMC Cancer. 2015 Mar 26;15:180. doi: 10.1186/s12885-015-1199-8.

18.

Neo-adjuvant therapy improves resectability rates for colorectal liver metastases.

Shankar A, Leonard P, Renaut AJ, Lederman J, Lees WR, Gillams AR, Harrison E, Taylor I.

Ann R Coll Surg Engl. 2001 Mar;83(2):85-8.

19.

Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.

John SK, Robinson SM, Rehman S, Harrison B, Vallance A, French JJ, Jaques BC, Charnley RM, Manas DM, White SA.

Dig Surg. 2013;30(4-6):293-301. doi: 10.1159/000354310. Epub 2013 Aug 21.

PMID:
23969407
20.

Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases.

Tanaka K, Shimada H, Ueda M, Matsuo K, Endo I, Sekido H, Togo S.

Surgery. 2006 May;139(5):599-607.

PMID:
16701091

Supplemental Content

Support Center